Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes
- PMID: 3100768
Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes
Abstract
Amphetamine, 10(-7) M or greater, evoked the release of [3H]dopamine ([3H]DA) and inhibited subsequent K+-evoked [3H]DA release from striatal synaptosomes superfused at a flow rate (1 ml/min) that prevented reuptake. Amphetamine inhibited the K+-evoked release of [3H]DA to a lesser extent in striatal slices or in synaptosomes superfused at a flow rate (0.35 ml/min) that allowed reuptake. The observed decrease in amphetamine inhibition of K+-evoked release was primarily due to amphetamine blocking [3H]DA reuptake. Interneuronal interactions may account for some of the inhibitory effects of amphetamine on K+-evoked release in the slice. Inhibition of K+-evoked release from either slices or synaptosomes was still evident when 10(-6) M amphetamine was removed from the superfusion buffer and the spontaneous release had returned to control levels. The presence of Ca++ during amphetamine exposure was required for subsequent inhibition of K+-evoked release in synaptosomes. Amphetamine in the presence of Ca++ did not affect the subsequent release of [3H]DA evoked by the Ca++ ionophore, A23187. Therefore, amphetamine inhibition of the K+-evoked release of [3H]DA cannot be explained by prior depletion of Ca++-releasable pools. Nifedipine, 1 microM, failed to block either the Ca++-dependent release of [3H]DA or the inhibition of K+-evoked release by amphetamine. However, 1 mM cobalt inhibited the Ca++-dependent release of [3H]DA by amphetamine and antagonized the inhibition of K+-evoked release after amphetamine exposure. This suggests that amphetamine may open voltage-dependent Ca++ channels sensitive to cobalt but not nifedipine. Amphetamine may desensitize these voltage-dependent Ca++ channels and inhibit their activation by K+ depolarization.
Similar articles
-
Modulation of the Ca++-evoked release of [3H]dopamine from striatal synaptosomes by dopamine (D2) agonists and antagonists.J Pharmacol Exp Ther. 1987 Apr;241(1):27-33. J Pharmacol Exp Ther. 1987. PMID: 3572788
-
Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes.J Pharmacol Exp Ther. 1984 Jun;229(3):671-80. J Pharmacol Exp Ther. 1984. PMID: 6726652
-
Ca2(+)-evoked [3H]dopamine release from synaptosomes is dependent on neuronal type Ca2+ channels and is not mediated by acetylcholine, glutamate or aspartate release.J Pharmacol Exp Ther. 1990 Aug;254(2):664-70. J Pharmacol Exp Ther. 1990. PMID: 1974645
-
Compartmentation of synaptosomal dopamine.Adv Biochem Psychopharmacol. 1978;19:57-73. Adv Biochem Psychopharmacol. 1978. PMID: 358787 Review. No abstract available.
-
Classification of H₂O₂as a neuromodulator that regulates striatal dopamine release on a subsecond time scale.ACS Chem Neurosci. 2012 Dec 19;3(12):991-1001. doi: 10.1021/cn300130b. Epub 2012 Nov 8. ACS Chem Neurosci. 2012. PMID: 23259034 Free PMC article. Review.
Cited by
-
Presynaptic control of serotonin on striatal dopamine function.Psychopharmacology (Berl). 2011 Feb;213(2-3):213-42. doi: 10.1007/s00213-010-2029-y. Epub 2010 Oct 16. Psychopharmacology (Berl). 2011. PMID: 20953589 Review.
-
Psychostimulant Effect of the Synthetic Cannabinoid JWH-018 and AKB48: Behavioral, Neurochemical, and Dopamine Transporter Scan Imaging Studies in Mice.Front Psychiatry. 2017 Aug 4;8:130. doi: 10.3389/fpsyt.2017.00130. eCollection 2017. Front Psychiatry. 2017. PMID: 28824464 Free PMC article.
-
Characterization of divalent cation-induced [3H]acetylcholine release from EGTA-treated rat hippocampal synaptosomes.Neurochem Res. 1991 Oct;16(10):1175-85. doi: 10.1007/BF00966598. Neurochem Res. 1991. PMID: 1795760
-
Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals.J Neurosci. 2013 Jan 9;33(2):452-63. doi: 10.1523/JNEUROSCI.2136-12.2013. J Neurosci. 2013. PMID: 23303926 Free PMC article.
-
Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release.J Neurochem. 2010 Oct;115(2):325-32. doi: 10.1111/j.1471-4159.2010.06922.x. Epub 2010 Aug 25. J Neurochem. 2010. PMID: 20649837 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical